Variant report
Variant | esv1003325 |
---|---|
Chromosome Location | chr9:104441313-104447221 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs62576306 | chr9:104441380-104441381 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs192270655 | chr9:104441429-104441430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183645311 | chr9:104441451-104441452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117555361 | chr9:104441520-104441521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187899796 | chr9:104441527-104441528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539346162 | chr9:104441595-104441596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371217061 | chr9:104441596-104441597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556403966 | chr9:104441676-104441677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4742822 | chr9:104441754-104441755 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs74887116 | chr9:104441755-104441756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371710902 | chr9:104441759-104441760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545311285 | chr9:104441760-104441761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565063813 | chr9:104441764-104441765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4742823 | chr9:104441772-104441773 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs540272018 | chr9:104441790-104441791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112817532 | chr9:104441853-104441854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190643632 | chr9:104441855-104441856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201148783 | chr9:104441862-104441863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373807665 | chr9:104442046-104442047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2506349 | chr9:104442128-104442129 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs549130280 | chr9:104442139-104442140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563118336 | chr9:104442169-104442170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371874905 | chr9:104442213-104442214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552034884 | chr9:104442221-104442222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147649529 | chr9:104442256-104442257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs533764186 | chr9:104442336-104442337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547416994 | chr9:104442339-104442340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567328268 | chr9:104442367-104442368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536370468 | chr9:104442378-104442379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556057869 | chr9:104442504-104442505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114541898 | chr9:104442587-104442588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375157876 | chr9:104442604-104442605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2506350 | chr9:104442646-104442647 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs572057865 | chr9:104442656-104442657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141529939 | chr9:104442680-104442681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2506351 | chr9:104442736-104442737 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs182753051 | chr9:104442772-104442773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373869885 | chr9:104442815-104442816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536129513 | chr9:104442817-104442818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552420019 | chr9:104442862-104442863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116923404 | chr9:104442872-104442873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570524178 | chr9:104443008-104443009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528199196 | chr9:104443027-104443028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546720677 | chr9:104443033-104443034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12344841 | chr9:104443077-104443078 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs145389693 | chr9:104443103-104443104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551734339 | chr9:104443123-104443124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145246871 | chr9:104443209-104443210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187084930 | chr9:104443213-104443214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192296684 | chr9:104443220-104443221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 22522925 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:104440000-104441800 | Enhancers | Fetal Heart | heart |
2 | chr9:104441400-104441800 | Enhancers | Fetal Lung | lung |
3 | chr9:104441800-104445400 | Weak transcription | Fetal Lung | lung |
4 | chr9:104443200-104443400 | Enhancers | Fetal Brain Male | brain |
5 | chr9:104443200-104446000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
6 | chr9:104443400-104444800 | Weak transcription | Fetal Brain Male | brain |
7 | chr9:104444800-104445000 | Enhancers | Fetal Brain Male | brain |
8 | chr9:104445000-104445800 | Weak transcription | Fetal Brain Male | brain |
9 | chr9:104445400-104445600 | Active TSS | Fetal Lung | lung |
10 | chr9:104445600-104445800 | Flanking Active TSS | Fetal Lung | lung |
11 | chr9:104445800-104446400 | Enhancers | Fetal Brain Male | brain |
12 | chr9:104445800-104446400 | Enhancers | Fetal Lung | lung |
13 | chr9:104446400-104451200 | Weak transcription | Fetal Lung | lung |
14 | chr9:104446400-104451800 | Weak transcription | Fetal Brain Male | brain |